TrialInternational journal of antimicrobial agents2022

High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.

Dora Buonfrate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.